Abstract
Excision Repair Cross-Complementation Group 1 (ERCC1) Polymorphism Predicted Platinum-Based Chemotherapy Treatment Outcome in Cholangiocarcinoma
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have